70 related articles for article (PubMed ID: 3140075)
1. [Plasma levels of von Willebrand factor in patients under integrated surgical-chemical therapy for ovarian cancer].
Facchini V; Gadducci A; Del Bravo B; Baicchi U; Manfredini C; Lelli L; Fioretti P
Minerva Ginecol; 1988 Apr; 40(4):231-4. PubMed ID: 3140075
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus.
Nossent AY; Ellenbroek JH; Frölich M; Bertina RM; Knoers NV; Eikenboom JC
Thromb Res; 2010 Jun; 125(6):554-6. PubMed ID: 20430418
[No Abstract] [Full Text] [Related]
4. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative plasma levels of von Willebrand factor in patients with cervical carcinoma].
Gadducci A; Baicchi U; Del Bravo B; Facchini V; Vispi M; Fioretti P
Minerva Ginecol; 1988 Mar; 40(3):159-62. PubMed ID: 3140074
[No Abstract] [Full Text] [Related]
6. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
[No Abstract] [Full Text] [Related]
8. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma.
Gadducci A; Baicchi U; Marrai R; Del Bravo B; Fosella PV; Facchini V
Gynecol Oncol; 1994 Jun; 53(3):352-6. PubMed ID: 8206409
[TBL] [Abstract][Full Text] [Related]
10. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
11. Standards for assay of von Willebrand factor concentrates: a collaborative study.
Fricke WA; Lamb MA; Rastogi SC
Thromb Haemost; 1993 Aug; 70(2):351-6. PubMed ID: 8236147
[TBL] [Abstract][Full Text] [Related]
12. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
13. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
[TBL] [Abstract][Full Text] [Related]
14. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand Factor.
Coca M; Cucuianu M; Hâncu N
Rom J Intern Med; 2005; 43(1-2):115-26. PubMed ID: 16739871
[TBL] [Abstract][Full Text] [Related]
15. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
16. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
[No Abstract] [Full Text] [Related]
17. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
Budde U; Drewke E
Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
Yorde LD; Yorde DE; Sasse EA; Hussey CV
Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
[TBL] [Abstract][Full Text] [Related]
20. The in vitro association of antihemophilic factor and von Willebrand factor.
Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
